bioRxiv Science⌕ Search

Biology subjects

Haroon, M. M.

Publications and source records attributed to Haroon, M. M..

2 recordsLinked to original sources

Single-cell transcriptomics reveal ddx43+ cells as regulators of slow-cycling neoblasts in planaria

Cell cycle dynamics are fundamental to stem cell maintenance and differentiation. While the G1 phase is known to influence stem cell fate decisions, the mechanisms regulating its duration remain poorly understood. Using Schmidtea mediterranea, a highly tractable model for studying regeneration, we uncovered how the interplay of systemic and local cues from specialized cell types regulates G1 phase progression, thereby priming the cells in a slow-cycling state poised to differentiate. Single-cell transcriptomics identified G1-enriched, non-committed neoblasts that give rise to a previously uncharacterized ddx43 cell type, localized near sub-epidermal muscle and closely associated with surrounding neoblasts. Functional analyses revealed that ddx43 cells act as gatekeepers, maintaining adjacent neoblasts in an extended G1 phase and a differentiation-primed state. ddx43 knockdown led to neoblast hyperproliferation, highlighting their niche-like regulatory role. Following injury, extracellular signal-regulated kinase (Erk) signalling that propagates to distal regions via subepidermal muscle cells is critical for suppression of ddx43 cells by downregulating Notch signalling. This establishes a critical cross-talk between sub-epidermal muscle and ddx43 cells, mediated by the Erk-Notch axis, essential for maintaining G1 phase extension. In summary, we reveal a ddx43-dependent, non-cell autonomous mechanism that regulates a transient, slow-cycling neoblast population, offering new insights into how extrinsic cues orchestrate stem cell cycling during tissue homeostasis and regeneration.

developmental biology↗

Delivery of BACE1 siRNA mediated by TARBP-BTP fusion protein reduces β-amyloid deposits in a transgenic mouse model of Alzheimers disease

Systemic delivery of nucleic acids to the central nervous system (CNS) is a major challenge for the development of RNA interference-based therapeutics due to absence of stability, target specificity, non-permeability to the blood-brain barrier (BBB), and mainly due to lack of suitable carriers. Using a designed bi-functional fusion protein TARBP-BTP, very recently we demonstrated knockdown of target genes in the brain of both A{beta}PP-PS1 (Alzheimers disease, AD) and wildtype C57BL/6 mice upon systemic delivery of a single dose of siRNA. In this report, we further substantiate this hypothesis through an extended study in A{beta}PP-PS1 mice, which upon treatment with seven doses of {beta}-secretase APP cleaving Enzyme 1 (BACE1) siRNA, led to target-specific effects in the mouse brain. Concomitant gene silencing and consequent reduction in plaque load in the cerebral cortex and hippocampus (>60%) in mice treated with TARBP-BTP:siRNA complex further led to improvement in spatial learning and memory, which was assessed and verified through Morris Water Maze test that revealed significant improvement in cognitive function. Moreover, the treatment did not induce any adverse effects as revealed by the histopathology of different organs. The work validates the efficiency of TARBP-BTP fusion protein as an efficient mediator of RNAi giving considerable scope for future intervention of neurodegenerative disorders of the CNS through the use of short nucleic acids as gene specific inhibitors.

neuroscience↗